Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides

Acta Dermato-Venereologica

Volumn 85, Issue 4, 2005, Pages 329-332

  Weber, Florian ^a   Schmuth, Matthias ^a   Sepp, Norbert ^a   Fritsch, Peter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Lymphoma; Mycosis fungoides; PUVA; Skin

Indexed keywords

CARMUSTINE; CHLORMETHINE; METHOXSALEN;

ADULT; ARTICLE; BALNEOTHERAPY; BEAM THERAPY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELECTRON BEAM; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MYCOSIS FUNGOIDES; OUTCOMES RESEARCH; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; RADIATION DOSE; RELAPSE; ULTRAVIOLET A RADIATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; BATHS; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; MYCOSIS FUNGOIDES; PUVA THERAPY; RADIATION DOSAGE; RADIATION-SENSITIZING AGENTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 23444447256     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510032814     Document Type: Article

References (36)

1. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107.
2. Dummer R, Kempf W, Hess Schmid M, Häffner A, Burg G. Therapy of cutaneous lymphoma - current practice and future developments. Onkologie 2003; 26: 366-372.
3. Gilchrest BA, Parrish JA, Tanenbaum L. Oral methoxypsoralen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-689.
4. Konrad K, Gschnait F, Hönigsmann H, Fritsch P, Wolff K. Photochemotherapy in mycosis fungoides. Hautarzt 1978; 29: 191-197.
5. Hönigsmann H, Brenner W, Rauschmeier W, Konrad K, Wolff K. Photochemotherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1984; 10: 238-245.
6. Roenigk H, Kuzel T, Skoutelis A, Springer E, Yu G, Caro W, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990; 95: 198S-205S.
7. Holloway KB, Flowers FP, Ramos-Caro FA. Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992; 27: 367-378.
8. Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995; 33: 234-242.
9. Roupe G, Sandström MH, Kjellström C. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. Acta Derm Venereol 1996; 76: 475-478.
10. Watson A. Photochemotherapy for mycosis fungoides: current status. Australas J Dermatol 1997; 38: 9-11.
11. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol 1976; 56: 383-390.
12. Lowe NJ, Weingarten D, Bourget T, Moy LS. PUVA treatment for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol 1986; 14: 754-760.
13. Salomon N, Walchner M, Messer G, Plewig G, Röcken M. Bath-PUVA therapy of granuloma annulare. Hautarzt 1999; 50: 275-279.
14. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000; 142: 39-43.
15. von Kobyletzki G, Gruss C, Altmeyer P, Kerscher M. Balneophotochemotherapy of lichen ruber. Personal results and comparison with photochemotherapy modalities employed up to now. Hautarzt 1997; 48: 323-327.
16. von Kobyletzki G, Freitag M, Hoffmann K, Altmeyer P, Kerscher M. Balneophotochemotherapy with 8-methoxypsoralen in lichen sclerosus et atrophicus. Hautarzt 1997; 48: 488-491.
17. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Röcken M. Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet 1994; 343: 1233.
18. Schempp CM, Müller H, Czech W, Schopf E, Simon JC. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997; 36: 733-737.
19. Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 1999; 15: 47-51.
20. Kowalzick L, Ott A, Waldmann T, Suckow M, Pönnighaus JM. Therapy of lymphomatoid papulosis with balneo-PUVA-photochemotherapy. Hautarzt 2000; 51: 778-780.
21. Collins P, Rogers S. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 1992; 127: 392-395.
22. Cooper EJ, Herd RM, Priestly GC, Hunter JA. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol 2000; 25: 111-114.
23. Fischer T, Skogh M. Treatment of parapsoriasis en plaques, mycosis fungoides, and Sezary's syndrome with trioxsalen baths followed by ultraviolet light. Acta Derm Venereol 1979; 59: 171-173.
24. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through IV. Arch Dermatol 1988; 124: 869-871.
25. Bunn PJ, Lamberg S. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725-728.
26. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (Limited patch and plaque) mycosis fungoides. Arch Dermatol 1996; 132: 1309-1313.
27. Lüftl M, Degitz K, Plewig G, Röcken M. Psoralen bath plus UVA-therapy. Arch Dermatol 1997; 133: 1597-1603.
28. Kerscher M, Lehmann P, Plewig G. PUVA-Bad-Therapie. Hautarzt 1994; 45: 526-528.
29. Röcken M, Plewig G. Bad-PUVA-Photochemotherapie. In: Krutmann J, Hönigsmann H, editors. Handbuch der dermatologischen Phototherapie und Photodiagnostik. Berlin: Springer, 1997: 259-279.
30. Diederen P, van Welden H, Sanders C, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48: 215-219.
31. Gilchrest BA. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat Rep 1979; 63: 663-667.
32. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-242.
33. Vallat V, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N, et al. PUVA-bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994; 180: 283-296.
34. Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Berne B. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol 1992; 128: 1341-1344.
35. Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesson A, Berne B, et al. PUVA and cancer: a large scale epidemiologic study. Lancet 1991; 338: 91-93.
36. David M, Lowe N, Halder R, Borok M. Serum 8-methoxypsoralen (8-MOP) concentrations after bath-water delivery of 8-MOP plus UVA. J Am Acad Dermatol 1990; 23: 931-932.